Informed-money record

LGND · LIGAND PHARMACEUTICALS INCORPORATED

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

Bearish filings

146

Named actors

Disclosed $ (bull / bear)

$514K / $60.9M

Recent disclosures

25 of 164 in the window · linked to source

Date	Who	What	Disclosed $	Receipt
2026-09-03	Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) ANDREW REARDON	filed notice to sell	$4.3M	SEC ↗
2026-08-12	Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) Jason Haas	filed notice to sell	$2.1M	SEC ↗
2026-08-12	Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) OCTAVIO ESPINOZA	filed notice to sell	$9.1M	SEC ↗
2026-08-03	CLO & Secretary Reardon Andrew	sold	$289K	SEC ↗
2026-08-03	CLO & Secretary Reardon Andrew	sold	$296K	SEC ↗

139 more disclosures in the window — the full record, scoring, and validation are for members.

Want the read, not just the record?

Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.

Create a free account →

Dispute or correct this record

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals